Trial Profile
A Randomized, Open-label, Fed, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Dec 2020
Price :
$35
*
At a glance
- Drugs CKD 385 (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 27 Nov 2018 New trial record